AR219709A1 - Procediemento para la preparacion de 2,3-alquilen-bis(oxi) benzamidas sustituidas - Google Patents

Procediemento para la preparacion de 2,3-alquilen-bis(oxi) benzamidas sustituidas

Info

Publication number
AR219709A1
AR219709A1 AR26867377A AR26867377A AR219709A1 AR 219709 A1 AR219709 A1 AR 219709A1 AR 26867377 A AR26867377 A AR 26867377A AR 26867377 A AR26867377 A AR 26867377A AR 219709 A1 AR219709 A1 AR 219709A1
Authority
AR
Argentina
Prior art keywords
benzamidas
alquilen
oxi
bis
substituted
Prior art date
Application number
AR26867377A
Other languages
English (en)
Spanish (es)
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7623835A external-priority patent/FR2360305A1/fr
Application filed by Ile De France filed Critical Ile De France
Application granted granted Critical
Publication of AR219709A1 publication Critical patent/AR219709A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AR26867377A 1976-08-04 1977-08-08 Procediemento para la preparacion de 2,3-alquilen-bis(oxi) benzamidas sustituidas AR219709A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7623835A FR2360305A1 (fr) 1976-08-04 1976-08-04 Nouveaux 2,3-alkylene bis (oxy)benzamides substitues, leurs derives et leurs procedes de preparation

Publications (1)

Publication Number Publication Date
AR219709A1 true AR219709A1 (es) 1980-09-15

Family

ID=9176558

Family Applications (1)

Application Number Title Priority Date Filing Date
AR26867377A AR219709A1 (es) 1976-08-04 1977-08-08 Procediemento para la preparacion de 2,3-alquilen-bis(oxi) benzamidas sustituidas

Country Status (37)

Country Link
JP (1) JPS57167914A (sv)
AR (1) AR219709A1 (sv)
AT (1) AT358034B (sv)
AU (1) AU516033B2 (sv)
BE (1) BE857350A (sv)
BG (1) BG36496A3 (sv)
CA (1) CA1114371A (sv)
CH (1) CH629198A5 (sv)
CS (1) CS216246B2 (sv)
DD (1) DD133237A5 (sv)
DE (1) DE2760414C2 (sv)
DK (1) DK152366C (sv)
EG (1) EG12716A (sv)
ES (1) ES461175A1 (sv)
FI (1) FI63938C (sv)
GR (1) GR61351B (sv)
HK (2) HK40382A (sv)
HU (1) HU179064B (sv)
IE (2) IE45646B1 (sv)
IL (2) IL52644A0 (sv)
IN (1) IN145473B (sv)
LU (1) LU77897A1 (sv)
MC (1) MC1154A1 (sv)
MW (1) MW2077A1 (sv)
NL (1) NL172063C (sv)
NO (1) NO152133C (sv)
NZ (1) NZ184816A (sv)
OA (1) OA05728A (sv)
PH (3) PH22114A (sv)
PL (1) PL111071B1 (sv)
PT (1) PT66865B (sv)
RO (1) RO72963A (sv)
SE (2) SE440776B (sv)
SU (1) SU716523A3 (sv)
YU (1) YU40005B (sv)
ZA (1) ZA774701B (sv)
ZM (1) ZM6077A1 (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9027098D0 (en) * 1990-12-13 1991-02-06 Beecham Group Plc Pharmaceuticals
US10083697B2 (en) 2015-05-27 2018-09-25 Google Llc Local persisting of data for selectively offline capable voice action in a voice-enabled electronic device
JP6452575B2 (ja) * 2015-08-19 2019-01-16 株式会社トクヤマ ミルタザピンの製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1473829A (fr) * 1964-06-09 1967-03-24 Ile De France Nu-(tertiaire-aminoalkyl)-méthylène dioxybenzamides et leur préparation

Also Published As

Publication number Publication date
AU516033B2 (en) 1981-05-14
PT66865B (fr) 1978-12-29
IN145473B (sv) 1978-10-21
PT66865A (fr) 1977-08-01
EG12716A (en) 1979-09-30
CA1114371A (en) 1981-12-15
HU179064B (en) 1982-08-28
FI772362A (sv) 1978-02-05
IE45647B1 (en) 1982-10-20
ZA774701B (en) 1979-01-31
NL7708616A (nl) 1978-02-07
PL200066A1 (pl) 1978-09-11
DK152366B (da) 1988-02-22
PH17710A (en) 1984-11-19
ZM6077A1 (en) 1979-05-21
AU2750777A (en) 1979-02-08
ES461175A1 (es) 1978-12-01
DD133237A5 (de) 1978-12-20
SE8206546D0 (sv) 1982-11-17
OA05728A (fr) 1981-05-31
DE2760414C2 (sv) 1990-05-17
HK40482A (en) 1982-09-24
MC1154A1 (fr) 1978-04-17
BE857350A (fr) 1978-02-01
PL111071B1 (en) 1980-08-30
JPS57167914A (en) 1982-10-16
DK152366C (da) 1988-07-25
CS216246B2 (en) 1982-10-29
SE437027B (sv) 1985-02-04
IE45646L (en) 1978-02-04
BG36496A3 (en) 1984-11-15
RO72963A (ro) 1981-11-24
LU77897A1 (sv) 1978-02-09
NO152133B (no) 1985-04-29
GR61351B (en) 1978-10-26
FI63938B (fi) 1983-05-31
SE7708849L (sv) 1978-02-05
NL172063B (nl) 1983-02-01
SE8206546L (sv) 1982-11-17
SU716523A3 (ru) 1980-02-15
YU188277A (en) 1983-01-21
PH18629A (en) 1985-08-23
IL66138A0 (en) 1982-09-30
FI63938C (fi) 1983-09-12
ATA569677A (de) 1980-01-15
IE802409L (en) 1978-02-04
HK40382A (en) 1982-09-24
NO152133C (no) 1985-08-07
PH22114A (en) 1988-06-01
SE453390B (sv) 1988-02-01
DK346977A (da) 1978-02-05
NL172063C (nl) 1983-07-01
IL52644A0 (en) 1977-10-31
SE440776B (sv) 1985-08-19
CH629198A5 (fr) 1982-04-15
IE45646B1 (en) 1982-10-20
JPS6259090B2 (sv) 1987-12-09
MW2077A1 (en) 1978-12-13
NO772739L (no) 1978-02-07
NZ184816A (en) 1980-11-14
YU40005B (en) 1985-06-30
AT358034B (de) 1980-08-11

Similar Documents

Publication Publication Date Title
AR222007A1 (es) Procedimiento para la preparacion de nuevos hentriacontapeptidos
MX6046E (es) Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles
AR215000A1 (es) Procedimiento para la preparacion de c-076
MX4089E (es) Procedimiento mejorado para la preparacion de n-fosfonometilglicina
IT1116742B (it) Procedimento per la preparazione di bis-immidi aromatiche
MX146421A (es) Procedimiento mejorado para la preparacion de confuesto di (bis (tri-alcoxisiloxi) alquilsiloxi) alcanos
AR220683A1 (es) Procedimiento para la preparacion de m-fenoxibenzaldehido
AR220684A1 (es) Metodo para la preparacion de 1-fenil-3-azabiciclo(3.1.0)hexanos
AR215875A1 (es) Procedimiento para la prepararacion de meta-fenoxi-benzaldehido
MX6242E (es) Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
MX4972E (es) Procedimiento mejorado para la preparacion de 7 beta-oxiimmino-acilcefalosporinas
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
MX5529E (es) Procedimiento para la preparacion de indolo-(2,3-a)-quinolizidinas
ES493650A0 (es) Procedimiento para la fabricacion de 2(3,4,5-trimetoxifenil)tiazoles,4,5-disubstituidos
ES456483A0 (es) Procedimiento para la preparacion de compuestos de estilbeno.
MX4161E (es) Procedimiento de preparacion de compuestos de amino-alcoxi-4(2h)-piranona-2,3 substituidos condensados-5,62
AR213430A1 (es) Procedimiento para la preparacion de nuevas n-cianoalquil-p-halofenoxi-isobutiramidas
SE436026B (sv) Forfarande for framstellning av 13,14-dehydroprostaglandiner
RO75589A (ro) Procedeu pentru prepararea 2,6-metan-2h-1-benzoxocinei
MX5685E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tio-substituido)-pirrol
MX6009E (es) Procedimiento para la preparacion de tetrahidro-1,3,5-tiadiazin-4-onas
MX4750E (es) Procedimiento para la preparacion de gamma-pironas
AR230642A1 (es) Procedimiento para la preparacion de un indoledihidroindolcarboxamida dimerica
MX144201A (es) Procedimiento mejorado para la preparacion de ciclohexanodionas (1,3)
MX147640A (es) Procedimiento para la preparacion de compuestos de 4 6-5-beta-sulfatoetilsulfonil-2-amino-fenol